Skip to main content

Bioengineered Microbes in Disease Therapy

  • Chapter
  • First Online:
Microbial Diversity, Interventions and Scope
  • 570 Accesses

Abstract

The developments in biotechnology, genomics, proteomics, immunology, and metabolic engineering have provided with unprecedented applications of microbes to improve human health. Disease therapies are experimenting with new regimes to alleviate the problems of diseases. Bioengineered microbes present with ample opportunities to uniquely address the problem of ailments by increasing the length and breadth of the available options to tackle diseases. Microbial immunomodulation of the host, targeted killing of the tumor cells using microbes, and specific delivery of drugs into the host tissues are some of the examples of application of bioengineered microbes. Although history of the concept of possibility of using the microbes for tweaking the disease progression and therefore promoting human health is an old one, with recent research studies, the field has received a much needed impetus. In the future, the need is to establish more in vivo evidences for wide acceptance of therapies using bioengineered microbes as well as to demonstrate the extent of the possible horizontal transfer of such bioengineered genes in order to undertake its practical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al-Ramadi BK et al (2009) Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis. Clin Immunol 130:89–97

    Article  CAS  Google Scholar 

  • Barbé S et al (2006) The use of clostridial spores for cancer treatment. J Appl Microbiol 101:571–578

    Article  Google Scholar 

  • Chikazu D et al (2017) Evaluation of OK-432 injection therapy as possible primary treatment of intraoral ranula. J Oral Maxillofac Surg 75:336–342

    Article  Google Scholar 

  • Culligan EP, Hill C, Sleator RD (2009) Probiotics and gastrointestinal disease: Successes problems and future prospects,Gut Pathog 1(1):19. https://doi.org/10.1186/1757-4749-1-19. Published 23 Nov 2009

  • Das BK et al (2010) Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci 17:21

    Article  Google Scholar 

  • Forbes NS (2010) Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10:785–794

    Article  CAS  Google Scholar 

  • Gajda M et al (2007) Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine 25:4183–4192

    Article  Google Scholar 

  • Łukasiewicz K, Fol M (2018) Microorganisms in the treatment of cancer: advantages and limitations. J Immunol Res 2018:1–8

    Article  Google Scholar 

  • Macarthy EF (2006) The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 26:154–158

    Google Scholar 

  • Miwa S et al (2019) Current and emerging targets in immunotherapy for osteosarcoma. J Oncol 2019(11):1–8

    Article  Google Scholar 

  • Paton JC et al (2012) Bioengineered microbes in disease therapy. Trends Mol Med 18:417–425

    Article  CAS  Google Scholar 

  • Roberts NJ, Zhang L, Janku F et al (2014) Intratumoral injection of clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6(249):249ra111. https://doi.org/10.1126/scitranslmed.3008982

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shintani Y et al (2007) Intravesical instillation therapy with Bacillus Calmette–Guérin for superficial bladder cancer: study of the mechanism of Bacillus Calmette–Guérin immunotherapy. Int J Urol 14:140–146

    Article  CAS  Google Scholar 

  • Sun J-B, Duan J-H, Dai S-L, Ren J, Lin G, Jiang W, Li Y (2008) Preparation and anti-tumor efficiency evaluation of doxorubicinloaded bacterial magnetosomes: Magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense. Biotechnol Bioeng. https://doi.org/10.1002/bit.22011

  • Yu H et al (2011) Bacteria-mediated disease therapy. Appl Microbiol Biotechnol 92:1107–1113

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mehta, R. (2020). Bioengineered Microbes in Disease Therapy. In: Sharma, S., Sharma, N., Sharma, M. (eds) Microbial Diversity, Interventions and Scope. Springer, Singapore. https://doi.org/10.1007/978-981-15-4099-8_8

Download citation

Publish with us

Policies and ethics